Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Free Cash Flow (2016 - 2025)

Avanos Medical's Free Cash Flow history spans 11 years, with the latest figure at $53.1 million for Q4 2024.

  • For Q4 2024, Free Cash Flow rose 680.88% year-over-year to $53.1 million; the TTM value through Dec 2024 reached $82.9 million, up 467.81%, while the annual FY2025 figure was $43.1 million, 48.01% down from the prior year.
  • Free Cash Flow for Q4 2024 was $53.1 million at Avanos Medical, up from $20.0 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $53.1 million in Q4 2024 and bottomed at -$12.1 million in Q1 2024.
  • The 5-year median for Free Cash Flow is $8.2 million (2021), against an average of $10.6 million.
  • The largest annual shift saw Free Cash Flow surged 1285.0% in 2021 before it crashed 237.5% in 2023.
  • A 5-year view of Free Cash Flow shows it stood at -$4.0 million in 2020, then soared by 1285.0% to $47.4 million in 2021, then tumbled by 39.24% to $28.8 million in 2022, then tumbled by 76.39% to $6.8 million in 2023, then soared by 680.88% to $53.1 million in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Free Cash Flow are $53.1 million (Q4 2024), $20.0 million (Q3 2024), and $21.9 million (Q2 2024).